This report was first published by Endpoints News. To see the original version, click here
Eli Lilly is shaking up its neuroscience and immunology leadership, while giving two longtime executives additional responsibilities.
The Indiana-based company said Thursday it has hired Carole Ho to be the president of its neuroscience division and promoted Adrienne Brown to president of immunology. Ho was most recently the chief medical officer at Denali Therapeutics, which has long worked on a suite of therapies for neurodegenerative diseases.
您已閱讀41%（539字），剩余59%（772字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。